Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds

Samy L Habib, Alaa F. Badawi, Hala A. Aweny, Mostafa H. Mostafa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

One tenth of the LD50 as a single dose of various N-nitroso compounds (N-nitrosodimethylamine; NDMA, N-nitrosodiethylamine; NDEA, N- nitrosoethylpropylamine; NEPA, N-nitrosodipropylamine; NDPA, N- nitrosomethylethylamine; NMEA, N-nitroso-methylbutylamine; NMBA and N- nitrosoethylbutylamine; NEBA) was administrated into male mice. This dose markedly increased the hepatic contents of cytochrome P450 and cytochrome b5 and activities of NADPH-cytochrome c reductase and aryl hydrocarbon hydroxylase (AHH). The highest increase in the activity of cytochrome P450 (+142% relative to the control value) was shown in animals treated with either N-nitrosoethylpropylamine or N-nitrosodiethylamine. On the other hand, the lowest increase in the activity (+16%) was revealed in animals treated with N-nitrosodimethylamine (not significant compared to the control value). Cytochrome b5 content was increased by 190% of the control value in mice treated with N-nitrosomethylbutylamine, while N-nitrosodibutylamine induced the lowest increase (+20%). The maximum increase (+182%) in the activity of aryl hydrocarbon hydroxylase was shown in animals which received N- nitrosomethylbutylamine, while the lowest increase (+23%) in animals which received N-nitrosodiethylamine. The activity of hepatic AHH was also increased above the control value in animals treated with NDMA, NEBA NDPA, NMEA and NDBA by 138, 98, 90, 89 and 69%, respectively. Identically, NADPH- cytochrome c reductase activity was increased in animals which received NEPA, NMBA, NDMA, NMEA, NDPA, NEBA and NDEA by 202, 150, 110, 95, 94, 77 and 37%, respectively.

Original languageEnglish (US)
Pages (from-to)965-969
Number of pages5
JournalOncology Reports
Volume5
Issue number4
StatePublished - 1998
Externally publishedYes

Fingerprint

Nitroso Compounds
Carcinogens
Aryl Hydrocarbon Hydroxylases
Diethylnitrosamine
Liver
Cytochromes b5
Dimethylnitrosamine
NADPH-Ferrihemoprotein Reductase
dibutylnitrosamine
Cytochrome P-450 Enzyme System
Lethal Dose 50

Keywords

  • Aryl hydrocarbon hydroxylase
  • Cytochrome P450
  • N-nitroso compounds

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Habib, S. L., Badawi, A. F., Aweny, H. A., & Mostafa, M. H. (1998). Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds. Oncology Reports, 5(4), 965-969.

Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds. / Habib, Samy L; Badawi, Alaa F.; Aweny, Hala A.; Mostafa, Mostafa H.

In: Oncology Reports, Vol. 5, No. 4, 1998, p. 965-969.

Research output: Contribution to journalArticle

Habib, SL, Badawi, AF, Aweny, HA & Mostafa, MH 1998, 'Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds', Oncology Reports, vol. 5, no. 4, pp. 965-969.
Habib, Samy L ; Badawi, Alaa F. ; Aweny, Hala A. ; Mostafa, Mostafa H. / Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds. In: Oncology Reports. 1998 ; Vol. 5, No. 4. pp. 965-969.
@article{27ec0aa9c445426cacebc0cc0420974e,
title = "Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds",
abstract = "One tenth of the LD50 as a single dose of various N-nitroso compounds (N-nitrosodimethylamine; NDMA, N-nitrosodiethylamine; NDEA, N- nitrosoethylpropylamine; NEPA, N-nitrosodipropylamine; NDPA, N- nitrosomethylethylamine; NMEA, N-nitroso-methylbutylamine; NMBA and N- nitrosoethylbutylamine; NEBA) was administrated into male mice. This dose markedly increased the hepatic contents of cytochrome P450 and cytochrome b5 and activities of NADPH-cytochrome c reductase and aryl hydrocarbon hydroxylase (AHH). The highest increase in the activity of cytochrome P450 (+142{\%} relative to the control value) was shown in animals treated with either N-nitrosoethylpropylamine or N-nitrosodiethylamine. On the other hand, the lowest increase in the activity (+16{\%}) was revealed in animals treated with N-nitrosodimethylamine (not significant compared to the control value). Cytochrome b5 content was increased by 190{\%} of the control value in mice treated with N-nitrosomethylbutylamine, while N-nitrosodibutylamine induced the lowest increase (+20{\%}). The maximum increase (+182{\%}) in the activity of aryl hydrocarbon hydroxylase was shown in animals which received N- nitrosomethylbutylamine, while the lowest increase (+23{\%}) in animals which received N-nitrosodiethylamine. The activity of hepatic AHH was also increased above the control value in animals treated with NDMA, NEBA NDPA, NMEA and NDBA by 138, 98, 90, 89 and 69{\%}, respectively. Identically, NADPH- cytochrome c reductase activity was increased in animals which received NEPA, NMBA, NDMA, NMEA, NDPA, NEBA and NDEA by 202, 150, 110, 95, 94, 77 and 37{\%}, respectively.",
keywords = "Aryl hydrocarbon hydroxylase, Cytochrome P450, N-nitroso compounds",
author = "Habib, {Samy L} and Badawi, {Alaa F.} and Aweny, {Hala A.} and Mostafa, {Mostafa H.}",
year = "1998",
language = "English (US)",
volume = "5",
pages = "965--969",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds

AU - Habib, Samy L

AU - Badawi, Alaa F.

AU - Aweny, Hala A.

AU - Mostafa, Mostafa H.

PY - 1998

Y1 - 1998

N2 - One tenth of the LD50 as a single dose of various N-nitroso compounds (N-nitrosodimethylamine; NDMA, N-nitrosodiethylamine; NDEA, N- nitrosoethylpropylamine; NEPA, N-nitrosodipropylamine; NDPA, N- nitrosomethylethylamine; NMEA, N-nitroso-methylbutylamine; NMBA and N- nitrosoethylbutylamine; NEBA) was administrated into male mice. This dose markedly increased the hepatic contents of cytochrome P450 and cytochrome b5 and activities of NADPH-cytochrome c reductase and aryl hydrocarbon hydroxylase (AHH). The highest increase in the activity of cytochrome P450 (+142% relative to the control value) was shown in animals treated with either N-nitrosoethylpropylamine or N-nitrosodiethylamine. On the other hand, the lowest increase in the activity (+16%) was revealed in animals treated with N-nitrosodimethylamine (not significant compared to the control value). Cytochrome b5 content was increased by 190% of the control value in mice treated with N-nitrosomethylbutylamine, while N-nitrosodibutylamine induced the lowest increase (+20%). The maximum increase (+182%) in the activity of aryl hydrocarbon hydroxylase was shown in animals which received N- nitrosomethylbutylamine, while the lowest increase (+23%) in animals which received N-nitrosodiethylamine. The activity of hepatic AHH was also increased above the control value in animals treated with NDMA, NEBA NDPA, NMEA and NDBA by 138, 98, 90, 89 and 69%, respectively. Identically, NADPH- cytochrome c reductase activity was increased in animals which received NEPA, NMBA, NDMA, NMEA, NDPA, NEBA and NDEA by 202, 150, 110, 95, 94, 77 and 37%, respectively.

AB - One tenth of the LD50 as a single dose of various N-nitroso compounds (N-nitrosodimethylamine; NDMA, N-nitrosodiethylamine; NDEA, N- nitrosoethylpropylamine; NEPA, N-nitrosodipropylamine; NDPA, N- nitrosomethylethylamine; NMEA, N-nitroso-methylbutylamine; NMBA and N- nitrosoethylbutylamine; NEBA) was administrated into male mice. This dose markedly increased the hepatic contents of cytochrome P450 and cytochrome b5 and activities of NADPH-cytochrome c reductase and aryl hydrocarbon hydroxylase (AHH). The highest increase in the activity of cytochrome P450 (+142% relative to the control value) was shown in animals treated with either N-nitrosoethylpropylamine or N-nitrosodiethylamine. On the other hand, the lowest increase in the activity (+16%) was revealed in animals treated with N-nitrosodimethylamine (not significant compared to the control value). Cytochrome b5 content was increased by 190% of the control value in mice treated with N-nitrosomethylbutylamine, while N-nitrosodibutylamine induced the lowest increase (+20%). The maximum increase (+182%) in the activity of aryl hydrocarbon hydroxylase was shown in animals which received N- nitrosomethylbutylamine, while the lowest increase (+23%) in animals which received N-nitrosodiethylamine. The activity of hepatic AHH was also increased above the control value in animals treated with NDMA, NEBA NDPA, NMEA and NDBA by 138, 98, 90, 89 and 69%, respectively. Identically, NADPH- cytochrome c reductase activity was increased in animals which received NEPA, NMBA, NDMA, NMEA, NDPA, NEBA and NDEA by 202, 150, 110, 95, 94, 77 and 37%, respectively.

KW - Aryl hydrocarbon hydroxylase

KW - Cytochrome P450

KW - N-nitroso compounds

UR - http://www.scopus.com/inward/record.url?scp=0031842004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031842004&partnerID=8YFLogxK

M3 - Article

C2 - 9625856

AN - SCOPUS:0031842004

VL - 5

SP - 965

EP - 969

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -